Ardent Health (NYSE:ARDT – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.900-1.270 for the period, compared to the consensus EPS estimate of 1.400. The company issued revenue guidance of $6.4 billion-$6.7 billion, compared to the consensus revenue estimate of $6.7 billion.
Wall Street Analysts Forecast Growth
ARDT has been the topic of a number of research analyst reports. Royal Bank Of Canada decreased their price target on Ardent Health from $21.00 to $16.00 and set an “outperform” rating on the stock in a research report on Friday, November 14th. KeyCorp cut Ardent Health from an “overweight” rating to a “sector weight” rating in a report on Monday, November 17th. Morgan Stanley restated an “equal weight” rating and issued a $12.00 price objective (down from $22.00) on shares of Ardent Health in a research report on Friday, November 14th. Bank of America decreased their price target on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating on the stock in a research note on Thursday, November 13th. Finally, Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, November 23rd. Six research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $14.58.
Read Our Latest Stock Report on Ardent Health
Ardent Health Price Performance
Ardent Health (NYSE:ARDT – Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.03). The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.63 billion. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, analysts anticipate that Ardent Health will post 1.23 earnings per share for the current year.
Trending Headlines about Ardent Health
Here are the key news stories impacting Ardent Health this week:
- Neutral Sentiment: Multiple law firms and notices are reminding investors of a March 9 deadline to seek lead‑plaintiff status in lawsuits related to the company’s disclosures — this increases organized litigation activity but does not itself determine outcomes. UPCOMING DEADLINE: Ardent Health, Inc. (ARDT) Securities Fraud Class Action – March 9, 2026 Lead Plaintiff Deadline
- Negative Sentiment: Ardent reported Q4 EPS of $0.32, missing estimates (~$0.35) and posted revenue slightly below consensus; more importantly, FY‑2026 EPS guidance (0.90–1.27) is well below the ~1.40 consensus, raising near‑term earnings risk and prompting analyst/model revisions. Ardent Health, Inc. (ARDT) Lags Q4 Earnings and Revenue Estimates
- Negative Sentiment: Allegations surfaced about a $97M accounting “shock” and use of a rigid 180‑day cliff to reserve for uncollectible accounts — these collection/reserve questions are central to the lawsuits and could imply further write‑offs or restatements if validated. ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and “180-Day Cliff” Reserves
- Negative Sentiment: Several plaintiff firms have filed or opened formal investigations and class actions alleging securities fraud tied to the collection/reserves disclosures and a prior ~33% stock decline; mounting litigation increases potential legal costs, distraction for management, and outcome uncertainty. $ARDT Stock Drop: Lose Money when Ardent Health Stock Fell 33% Amid Collectability Issues? Contact BFA Law before March 9 Class Action Deadline
Institutional Investors Weigh In On Ardent Health
Several hedge funds have recently bought and sold shares of ARDT. Goldentree Asset Management LP grew its holdings in shares of Ardent Health by 99.7% in the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after buying an additional 1,150,000 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after acquiring an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Ardent Health by 75.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after purchasing an additional 703,739 shares in the last quarter. Bridgeway Capital Management LLC grew its position in shares of Ardent Health by 108.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after purchasing an additional 491,961 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in Ardent Health in the third quarter valued at approximately $6,377,000.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Featured Articles
- Five stocks we like better than Ardent Health
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
